Revance Therapeutics shares owned by Legato Capital Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Legato Capital Management
from 13F filings
Historical chart of Legato Capital Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Legato Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Legato Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $501k | 102k | 4.92 |
| 2023-12-31 | $507k | 58k | 8.79 |
| 2023-09-30 | $445k | 39k | 11.47 |
| 2023-06-30 | $1.0M | 40k | 25.31 |
| 2023-03-31 | $1.1M | 33k | 32.21 |
| 2022-12-31 | $617k | 33k | 18.46 |